Sihuan Pharmaceutical Holdings Group Ltd. Announces 2012 Annual Results
3/25/2013 9:35:45 AM
More...
|
SFDA Grants Approval to Sihuan Pharmaceutical Holdings Group Ltd. for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
2/22/2013 8:56:19 AM
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. 's Generic Drug Nalmefene Hydrochloride Receives Approval for Pharmaceutical Registration From State FDA
1/16/2013 9:20:55 AM
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. Collaborates With NeuroVive Pharmaceutical AB to Develop Two Innovative Cardio-Cerebral Vascular Products in China
11/20/2012 9:02:07 AM
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. Announces SFDA Approval for Ulcer Drug
11/2/2012 2:54:15 PM
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. 's First-to-Market Generic Drug Roxatidine Receives New Drug Certificate and Approval for Production
10/31/2012 9:55:03 AM
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. Announces 2012 Interim Results
8/31/2012 9:24:17 AM
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. 's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration
5/29/2012 10:06:34 AM
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. Doubled its Revenue in 2011
3/20/2012 9:58:08 AM
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. Announces 2011 Annual Results
3/19/2012 10:26:11 AM
More...
|
|